FabRx 3D Prints Personalized Tablets for Treatment of Rare Metabolic Disease in Children
FabRx, a British 3D printed pharmaceuticals company, has developed personalized medicine for children with the rare metabolic disorder, maple syrup urine disease (MSUD).